H3K4 Acetylation, H3K9 Acetylation and H3K27 Methylation in Breast Tumor Molecular Subtypes

References

• Jemal A , BrayF , CenterMM , FerlayJ , WardE , FormanD . Global cancer statistics . CA Cancer J Clin.61 ( 2 ), 69 – 90 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Perou CM , SorlieT , EisenMBet al. Molecular portraits of human breast tumours . Nature406 ( 6797 ), 747 – 752 ( 2000 ).
   PubMed Web of Science ®Google Scholar
• Lehmann BD , BauerJA , ChenXet al. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies . J. Clin. Invest.121 ( 7 ), 2750 – 2767 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Chung CH , BernardPS , PerouCM . Molecular portraits and the family tree of cancer . Nat. Genet.32 ( Suppl. ), 533 – 540 ( 2002 ).
   PubMedGoogle Scholar
• Sorlie T , PerouCM , TibshiraniRet al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications . Proc. Natl Acad. Sci. USA98 ( 19 ), 10869 – 10874 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• Reis-Filho JS , PusztaiL . Gene expression profiling in breast cancer: classification, prognostication, and prediction . Lancet378 ( 9805 ), 1812 – 1823 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Bauer K , PariseC , CaggianoV . Use of ER/PR/HER2 subtypes in conjunction with the 2007 St Gallen Consensus Statement for early breast cancer . BMC Cancer10 , 228 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Ades F , ZardavasD , Bozovic-SpasojevicIet al. Luminal B breast cancer: molecular characterization, clinical management, and future perspectives . J. Clin. Oncol.32 ( 25 ), 2794 – 2803 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Cheang MC , ChiaSK , VoducDet al. Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer . J. Natl Cancer Inst.101 ( 10 ), 736 – 750 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Goldhirsch A , WoodWC , CoatesAS , GelberRD , ThurlimannB , SennHJ . Strategies for subtypes – dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011 . Ann. Oncol.22 ( 8 ), 1736 – 1747 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Goldhirsch A , WinerEP , CoatesASet al. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013 . Ann. Oncol.24 ( 9 ), 2206 – 2223 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Hanahan D , WeinbergRA . Hallmarks of cancer: the next generation . Cell144 ( 5 ), 646 – 674 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Elsheikh SE , GreenAR , RakhaEAet al. Global histone modifications in breast cancer correlate with tumor phenotypes, prognostic factors, and patient outcome . Cancer Res.69 ( 9 ), 3802 – 3809 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Li Y , LiS , ChenJet al. Comparative epigenetic analyses reveal distinct patterns of oncogenic pathways activation in breast cancer subtypes . Hum. Mol. Genet.23 ( 20 ), 5378 – 5393 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Schlesinger Y , StraussmanR , KeshetIet al. Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer . Nat. Genet.39 ( 2 ), 232 – 236 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Ohm JE , McgarveyKM , YuXet al. A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing . Nat. Genet.39 ( 2 ), 237 – 242 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Vire E , BrennerC , DeplusRet al. The Polycomb group protein EZH2 directly controls DNA methylation . Nature439 ( 7078 ), 871 – 874 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Schwartz YB , PirrottaV . Polycomb silencing mechanisms and the management of genomic programmes . Nat. Rev. Genet.8 ( 1 ), 9 – 22 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Margueron R , ReinbergD . The Polycomb complex PRC2 and its mark in life . Nature469 ( 7330 ), 343 – 349 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Cao R , WangL , WangHet al. Role of histone H3 lysine 27 methylation in Polycomb-group silencing . Science298 ( 5595 ), 1039 – 1043 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Bernstein BE , KamalM , Lindblad-TohKet al. Genomic maps and comparative analysis of histone modifications in human and mouse . Cell120 ( 2 ), 169 – 181 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Roth SY , DenuJM , AllisCD . Histone acetyltransferases . Annu. Rev. Biochem.70 , 81 – 120 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• Iyer NG , OzdagH , CaldasC . p300/CBP and cancer . Oncogene23 ( 24 ), 4225 – 4231 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Xu J , WuRC , O’MalleyBW . Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) family . Nat. Rev. Cancer9 ( 9 ), 615 – 630 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Judes G , RifaiK , NgolloMet al. A bivalent role of TIP60 histone acetyl transferase in human cancer . Epigenomics7 ( 8 ), 1351 – 1363 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Zhen L , Gui-LanL , PingY , JinH , Ya-LiW . The expression of H3K9Ac, H3K14Ac, and H4K20TriMe in epithelial ovarian tumors and the clinical significance . Int. J. Gynecol. Cancer20 ( 1 ), 82 – 86 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Mohamed MA , GreifPA , DiamondJet al. Epigenetic events, remodelling enzymes and their relationship to chromatin organization in prostatic intraepithelial neoplasia and prostatic adenocarcinoma . BJU Int.99 ( 4 ), 908 – 915 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Xhemalce B , KouzaridesT . A chromodomain switch mediated by histone H3 Lys 4 acetylation regulates heterochromatin assembly . Genes Dev.24 ( 7 ), 647 – 652 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Guillemette B , DrogarisP , LinHHet al. H3 lysine 4 is acetylated at active gene promoters and is regulated by H3 lysine 4 methylation . PLoS Genet.7 ( 3 ), e1001354 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Ngollo M , LebertA , DagdemirAet al. The association between Histone 3 Lysine 27 Trimethylation (H3K27me3) and prostate cancer: relationship with clinicopathological parameters . BMC Cancer14 ( 1 ), 994 ( 2014 ).
   PubMedGoogle Scholar
• Dagdemir A , DurifJ , NgolloM , BignonYJ , Bernard-GallonD . Histone lysine trimethylation or acetylation can be modulated by phytoestrogen, estrogen or anti-HDAC in breast cancer cell lines . Epigenomics5 ( 1 ), 51 – 63 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Livak KJ , SchmittgenTD . Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method . Methods25 ( 4 ), 402 – 408 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• Gross J , LiggesU . Nortest: Test for Normality . R. Package version 1.0–3. ( 2015 ). https://cran.r-project.org .
   Google Scholar
• Fox J , WeisbergS . An R Companion to Applied Regression, (Second Edition) . SAGE publications, Inc. , CA, USA ( 2011 ).
   Google Scholar
• De Mendiburu F . Agricolae: Statistical Procedures for Agricultural Research . R package version 1.2 –1. ( 2014 ). https://cran.r-project.org .
   Google Scholar
• Williams GJ . Dtat Mining with Rattle and R: The Art of Excavating Data for Knowledge Discovery, Use R! ( 2011 ). https://mineriaddatos.wikispaces.com .
   Google Scholar
• Therneau T , AtkinsonB , RipleyB . rpart: Recursive Partitioning and Regression Trees . R package version 4.1–9. ( 2015 ). https://cran.r-project.org .
   Google Scholar
• Venables WN , RipleyBD . Modern Apllied Statistics with S. (Fourth Edition) . Springer , NY, USA ( 2002 ).
   Google Scholar
• Todorov V , FilzmoserP . An object-oriented framework for robust multivariate analysis . J. Stat. Softw.32 ( 3 ), 1 – 47 ( 2009 ).
   Web of Science ®Google Scholar
• Liu Z , ZhangXS , ZhangS . Breast tumor subgroups reveal diverse clinical prognostic power . Sci. Rep.4 , 4002 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Schnitt SJ . Molecular biology of breast tumor progression: a view from the other side . Int. J. Surg. Pathol.18 ( Suppl. 3 ), S170 – S173 ( 2010 ).
   Web of Science ®Google Scholar
• Giacinti L , ClaudioPP , LopezM , GiordanoA . Epigenetic information and estrogen receptor alpha expression in breast cancer . Oncologist11 ( 1 ), 1 – 8 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Gaudet MM , CampanM , FigueroaJDet al. DNA hypermethylation of ESR1 and PGR in breast cancer: pathologic and epidemiologic associations . Cancer Epidemiol. Biomarkers Prev.18 ( 11 ), 3036 – 3043 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Kondo Y . Epigenetic cross-talk between DNA methylation and histone modifications in human cancers . Yonsei Med. J.50 ( 4 ), 455 – 463 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Perillo B , OmbraMN , BertoniAet al. DNA oxidation as triggered by H3K9me2 demethylation drives estrogen-induced gene expression . Science319 ( 5860 ), 202 – 206 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Turner NC , Reis-FilhoJS , RussellAMet al. BRCA1 dysfunction in sporadic basal-like breast cancer . Oncogene26 ( 14 ), 2126 – 2132 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Hosey AM , GorskiJJ , MurrayMMet al. Molecular basis for estrogen receptor alpha deficiency in BRCA1-linked breast cancer . J. Natl Cancer Inst.99 ( 22 ), 1683 – 1694 ( 2007 ).
   PubMedGoogle Scholar
• Spillman MA , BowcockAM . BRCA1 and BRCA2 mRNA levels are coordinately elevated in human breast cancer cells in response to estrogen . Oncogene13 ( 8 ), 1639 – 1645 ( 1996 ).
   PubMed Web of Science ®Google Scholar
• Marks JR , HuperG , VaughnJPet al. BRCA1 expression is not directly responsive to estrogen . Oncogene14 ( 1 ), 115 – 121 ( 1997 ).
   PubMed Web of Science ®Google Scholar
• Di LJ , FernandezAG , De SierviA , LongoDL , GardnerK . Transcriptional regulation of BRCA1 expression by a metabolic switch . Nat. Struct. Mol. Biol.17 ( 12 ), 1406 – 1413 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Matros E , WangZC , LodeiroG , MironA , IglehartJD , RichardsonAL . BRCA1 promoter methylation in sporadic breast tumors: relationship to gene expression profiles . Breast Cancer Res. Treat.91 ( 2 ), 179 – 186 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Fiegl H , MillingerS , GoebelGet al. Breast cancer DNA methylation profiles in cancer cells and tumor stroma: association with HER-2/neu status in primary breast cancer . Cancer Res.66 ( 1 ), 29 – 33 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Collett K , EideGE , ArnesJet al. Expression of enhancer of zeste homologue 2 is significantly associated with increased tumor cell proliferation and is a marker of aggressive breast cancer . Clin. Cancer Res.12 ( 4 ), 1168 – 1174 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Healey MA , HuR , BeckAHet al. Association of H3K9me3 and H3K27me3 repressive histone marks with breast cancer subtypes in the Nurses’ Health Study . Breast Cancer Res. Treat.147 ( 3 ), 639 – 651 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Kleer CG , CaoQ , VaramballySet al. EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells . Proc. Natl Acad. Sci. USA100 ( 20 ), 11606 – 11611 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Yang H , PinelloCE , LuoJet al. Small-molecule inhibitors of acetyltransferase p300 identified by high-throughput screening are potent anticancer agents . Mol. Cancer Ther.12 ( 5 ), 610 – 620 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Hudelist G , SingerCF , ManaviM , PischingerK , KubistaE , CzerwenkaK . Co-expression of ErbB-family members in human breast cancer: Her-2/neu is the preferred dimerization candidate in nodal-positive tumors . Breast Cancer Res. Treat.80 ( 3 ), 353 – 361 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Gojis O , RudrarajuB , GudiMet al. The role of SRC-3 in human breast cancer . Nat. Rev. Clin. Oncol.7 ( 2 ), 83 – 89 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Osborne CK , BardouV , HoppTAet al. Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer . J. Natl Cancer Inst.95 ( 5 ), 353 – 361 ( 2003 ).
   PubMedGoogle Scholar
• Yan PS , VenkataramuC , IbrahimAet al. Mapping geographic zones of cancer risk with epigenetic biomarkers in normal breast tissue . Clin. Cancer Res.12 ( 22 ), 6626 – 6636 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Bernstein BE , MikkelsenTS , XieXet al. A bivalent chromatin structure marks key developmental genes in embryonic stem cells . Cell125 ( 2 ), 315 – 326 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Wang Z , ZangC , RosenfeldJAet al. Combinatorial patterns of histone acetylations and methylations in the human genome . Nat. Genet.40 ( 7 ), 897 – 903 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Miranda TB , CortezCC , YooCBet al. DZNep is a global histone methylation inhibitor that reactivates developmental genes not silenced by DNA methylation . Mol. Cancer Ther.8 ( 6 ), 1579 – 1588 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Marks PA . Discovery and development of SAHA as an anticancer agent . Oncogene26 ( 9 ), 1351 – 1356 ( 2007 ).
   PubMed Web of Science ®Google Scholar